Naprosyn and Micro-k drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Naprosyn (naproxen) and Micro-k (potassium chloride). Common drug interactions include hypertension among females and chest pain among males.

The phase IV clinical study analyzes what interactions people have when they take Naprosyn and Micro-k. It is created by eHealthMe based on reports of 15 people who take the same drugs from the FDA, and is updated regularly.

What is Naprosyn?

Naprosyn has active ingredients of naproxen. It is often used in pain. eHealthMe is studying from 16,738 Naprosyn users. Check the latest studies of Naprosyn.

What is Micro-k?

Micro-k has active ingredients of potassium chloride. It is often used in hypokalemia. eHealthMe is studying from 1,895 Micro-k users. Check the latest studies of Micro-k.



On Jul, 14, 2026

15 people who take Naprosyn and Micro-k together, and have interactions are studied.

Naprosyn and Micro-k drug interactions.

What are the common drug interactions of Naprosyn and Micro-K, by gender? *:

female:

  1. Hypertension (high blood pressure)
  2. Alopecia (absence of hair from areas of the body)
  3. Depression
  4. Nervousness
  5. Anxiety
  6. Asthenia (weakness)
  7. Behcet's syndrome (involves inflammation of the blood vessels)
  8. Blood alkaline phosphatase increased
  9. Blood pressure decreased
  10. Diarrhoea

male:

  1. Chest pain
  2. Blood pressure increased
  3. Laboratory test abnormal
  4. Multiple myeloma (cancer of the plasma cells)
  5. Neuropathy (damage to nerves)
  6. Plasmacytoma (neoplasm of plasma cells (usually in bone marrow))
  7. Post herpetic neuralgia (neuralgia caused by the varicella zoster virus)
  8. Upper gastrointestinal haemorrhage (upper gastrointestinal bleeding)
  9. Dyspnoea exertional (breathlessness or shortness of breath)
  10. Myocardial infarction (destruction of heart tissue resulting from obstruction of the blood supply to the heart muscle)

What are the common drug interactions of Naprosyn and Micro-K, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

  1. Blood pressure increased
  2. Chest pain
  3. Dyspnoea exertional (breathlessness or shortness of breath)
  4. Oedema peripheral (superficial swelling)

60+:

  1. Chest pain
  2. Hypertension (high blood pressure)
  3. Atrioventricular block complete (heart block complete)
  4. Blood alkaline phosphatase increased
  5. Blood pressure decreased
  6. Blood pressure increased
  7. Cardiac arrest
  8. Cardiac murmur (an heart sound in valve abnormality)
  9. Coronary artery disease (plaque building up along the inner walls of the arteries of the heart, which narrows the arteries and restricts blood flow to the heart)
  10. Diarrhoea

What are the existing conditions these people have? *

  1. Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 3 people, 20.00%
  2. Crohn's Disease (a condition that causes inflammation of the gastrointestinal tract): 2 people, 13.33%
  3. Constipation: 2 people, 13.33%
  4. Stroke (sudden death of a portion of the brain cells due to a lack of oxygen): 1 person, 6.67%
  5. Stress And Anxiety: 1 person, 6.67%
  6. Sleep Disorder: 1 person, 6.67%
  7. Post Herpetic Neuralgia (neuralgia caused by the varicella zoster virus): 1 person, 6.67%
  8. Oedema (fluid collection in tissue): 1 person, 6.67%
  9. Multiple Myeloma (cancer of the plasma cells): 1 person, 6.67%
  10. Atrial Fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles): 1 person, 6.67%

* Approximation only. Some reports may have incomplete information.

Do you take Naprosyn and Micro-k?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Naprosyn and Micro-k:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Naprosyn:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Micro-k:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Naprosyn and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Micro-k and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on naproxen and potassium chloride (the active ingredients of Naprosyn and Micro-k, respectively), and Naprosyn and Micro-k (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: